Real-world evidence (RWE) can be used to inform the European Medicines Agency’s decision-making by filling in knowledge gaps in evidence submitted by pharmaceutical companies.
While companies themselves can generate RWE by conducting studies, the EMA also provides an evidence generation service based on requests from specific groups such as its own scientific committees and...